Retraction notice to “Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade" [Eur. J. Pharmacol 724 (2014) 43–50, (S0014299913009606), (10.1016/j.ejphar.2013.12.032)];Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade

European Journal of Pharmacology

Volumn 724, Issue 1, 2014, Pages 43-50

  Barakat, Waleed ^a   Safwet, Nancy ^a   El Maraghy, Nabila N ^a   Zakaria, Mohamed N M ^a  

^a Zagazig University   (Egypt)

Author keywords

Candesartan; Glycyrrhizin; MCAO; TLR

Indexed keywords

CANDESARTAN; CEREBROLYSIN; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CHIMNEY TEST; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENCEPHALITIS; INFLAMMATORY INFILTRATE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR COORDINATION; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TASK PERFORMANCE;

CANDESARTAN; GLYCYRRHIZIN; MCAO; TLR;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BEHAVIOR, ANIMAL; BENZIMIDAZOLES; BRAIN; BRAIN ISCHEMIA; CYTOKINES; DOWN-REGULATION; GLYCYRRHIZIC ACID; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERFERON REGULATORY FACTOR-3; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NEUROPROTECTIVE AGENTS; TETRAZOLES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84891794315     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2024.177018     Document Type: Erratum

References (52)

1. A. Ahmad, R. Crupi, M. Campolo, T. Genovese, E. Esposito, and S. Cuzzocrea Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice PLoS One 8 2013 e57208
2. X.A. Alvarez, V.R. Lombardi, L. Fernandez-Novoa, M. Garcia, C. Sampedro, A. Cagiao, R. Cacabelos, and M. Windisch Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection J. Neural. Transm. Suppl. 59 2000 281 292 (Pubitemid 30479428)
3. M.N. Asl, and H. Hosseinzadeh Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds Phytother. Res. 22 2008 709 724 (Pubitemid 351955567)
4. A.S. Awad Effect of combined treatment with curcumin and candesartan on ischemic brain damage in mice J. Stroke Cerebrovasc. Dis. 20 2011 541 548
5. F.C. Barone, B. Arvin, R.F. White, A. Miller, C.L. Webb, R.N. Willette, P.G. Lysko, and G.Z. Feuerstein Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury Stroke 28 1997 1233 1244 (Pubitemid 27248902)
6. J.B. Bederson, L.H. Pitts, M. Tsuji, M.C. Nishimura, R.L. Davis, and H. Bartkowski Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination Stroke 17 1986 472 476 (Pubitemid 16085691)
7. M. Carty, and A.G. Bowie Evaluating the role of Toll-like receptors in diseases of the central nervous system Biochem. Pharmacol. 81 2011 825 837
8. J.R. Caso, J.M. Pradillo, O. Hurtado, P. Lorenzo, M.A. Moro, and I. Lizasoain Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke Circulation 115 2007 1599 1608 (Pubitemid 46648645)
9. T. Chiang, R.O. Messing, and W.H. Chou Mouse model of middle cerebral artery occlusion J. Vis. Exp 2011
10. S. Cho, Y. Choi, S. Park, and T. Park Carvacrol prevents diet-induced obesity by modulating gene expressions involved in adipogenesis and inflammation in mice fed with high-fat diet J. Nutr. Biochem. 23 2011 192 201
11. M.R. Dasu, A.C. Riosvelasco, and I. Jialal Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo Atherosclerosis 202 2009 76 83
12. L. Edvinsson Cerebrovascular angiotensin AT1 receptor regulation in cerebral ischemia Trends Cardiovasc. Med. 18 2008 98 103 (Pubitemid 351626606)
13. T. Engelhorn, S. Goerike, A. Doerfler, C. Okorn, M. Forsting, G. Heusch, and R. Schulz The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats J. Cereb. Blood Flow Metab. 24 2004 467 474 (Pubitemid 38455442)
14. S.C. Fagan, and D.C. Hess Stroke J.T. DiPiro, Pharmacotherapy A Pathophysiologic Approach seventh ed. 2008 Mc Graw Hill Medical New York 373 384
15. N. Fahimfar, D. Khalili, R. Mohebi, F. Azizi, and F. Hadaegh Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran BMC Neurol. 12 2012 117
16. V. Gaur, and A. Kumar Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction Inflammopharmacology 19 2011 205 214
17. G. Gong, L.B. Yuan, L. Hu, W. Wu, L. Yin, J.L. Hou, Y.H. Liu, and L.S. Zhou Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1 Acta Pharmacol. Sin. 33 2012 11 18
18. W. Groth, A. Blume, P. Gohlke, T. Unger, and J. Culman Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats J. Hypertens. 21 2003 2175 2182 (Pubitemid 38296880)
19. M. Hamai, M. Iwai, A. Ide, H. Tomochika, Y. Tomono, M. Mogi, and M. Horiuchi Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress Neuropharmacology 51 2006 822 828 (Pubitemid 44376401)
20. H. Heinecke A comparison of two variants of the chimney behaviour test in mice Z. Versuchstierkd 29 1987 145 148
21. S.Z. Hou, Y. Li, X.L. Zhu, Z.Y. Wang, X. Wang, and Y. Xu Ameliorative effects of diammonium glycyrrhizinate on inflammation in focal cerebral ischemic-reperfusion injury Brain Res. 1447 2012 20 27
22. Y.Y. Hou, Y. Yang, Y. Yao, and G. Bai Neuroprotection of glycyrrhizin against ischemic vascular dementia in vivo and glutamate-induced damage in vitro Chin. Herb. Med. 2 2010 125 131
23. F. Hua, J. Ma, T. Ha, Y. Xia, J. Kelley, D.L. Williams, R.L. Kao, I. William Browder, J.B. Schweitzer, J.H. Kalbfleisch, and C. Li Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion J. Neuroimmunol. 190 2007 101 111 (Pubitemid 47625617)
24. S.W. Kim, Y. Jin, J.H. Shin, I.D. Kim, H.K. Lee, S. Park, P.L. Han, and J.K. Lee Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion Neurobiol. Dis. 46 2012 147 156
25. S.W. Kim, C.M. Lim, H.K. Lee, and J.K. Lee The use of stronger neo-minophagen C, a glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain Anat. Cell Biol. 44 2011 304 313
26. Y.J. Kim, and C.S. Lee Glycyrrhizin attenuates MPTP neurotoxicity in mouse and MPP-induced cell death in PC12 cells Korean J. Physiol. Pharmacol. 12 2008 65 71 (Pubitemid 351736661)
27. Y. Kong, and Y. Le Toll-like receptors in inflammation of the central nervous system Int. Immunopharmacol. 11 2011 1407 1414
28. J. Li, J. Culman, H. Hortnagl, Y. Zhao, N. Gerova, M. Timm, A. Blume, M. Zimmermann, K. Seidel, U. Dirnagl, and T. Unger Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury FASEB J. 19 2005 617 619 (Pubitemid 40471263)
29. Y. Li, P.J. Lein, C. Liu, D.A. Bruun, T. Tewolde, G. Ford, and B.D. Ford Spatiotemporal pattern of neuronal injury induced by DFP in rats: a model for delayed neuronal cell death following acute OP intoxication Toxicol. Appl. Pharmacol. 253 2011 261 269
30. V.R. Lombardi, M. Windisch, M. Garcia, and R. Cacabelos Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures Methods Find. Exp. Clin. Pharmacol. 21 1999 331 338 (Pubitemid 29291248)
31. Y. Ma, M. He, and L. Qiang Exercise therapy downregulates the overexpression of TLR4, TLR2, MyD88 and NF-kappaB after cerebral ischemia in rats Int. J. Mol. Sci. 14 2013 3718 3733
32. E. Masliah, and E. Diez-Tejedor The pharmacology of neurotrophic treatment with cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders Drugs Today (Barc.) 48 Suppl. A 2012 3 24
33. A.P. Mecca, T.E. O'Connor, M.J. Katovich, and C. Sumners Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion Exp. Physiol. 94 2009 937 946
34. M.A. Moskowitz, E.H. Lo, and C. Iadecola The science of stroke: mechanisms in search of treatments Neuron 67 2010 181 198
35. M. Neubert, D.A. Ridder, P. Bargiotas, S. Akira, and M. Schwaninger Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia Cell Death Differ. 18 2011 1521 1530
36. M. Ogiku, H. Kono, M. Hara, M. Tsuchiya, and H. Fujii Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats J. Pharmacol. Exp. Ther. 339 2011 93 98
37. J.B. Phillips, A.J. Williams, J. Adams, P.J. Elliott, and F.C. Tortella Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia Stroke 31 2000 1686 1693 (Pubitemid 30437524)
38. J. Ren, D. Sietsma, S. Qiu, H. Moessler, and S.P. Finklestein Cerebrolysin enhances functional recovery following focal cerebral infarction in rats Restor. Neurol. Neurosci. 25 2007 25 31 (Pubitemid 46631011)
39. N. Rothwell, S. Allan, and S. Toulmond The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications J. Clin. Invest. 100 1997 2648 2652 (Pubitemid 28007530)
40. K. Schmerbach, J.H. Schefe, M. Krikov, S. Muller, A. Villringer, U. Kintscher, T. Unger, and C. Thoene-Reineke Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain Brain Res. 1208 2008 225 233
41. B. Schrofelbauer, J. Raffetseder, M. Hauner, A. Wolkerstorfer, W. Ernst, and O.H. Szolar Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signaling Biochem. J. 421 2009 473 482
42. H.S. Sharma, S. Zimmermann-Meinzingen, and C.E. Johanson Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat Ann. N.Y. Acad. Sci. 1199 2010 125 137
43. T. Shichita, R. Sakaguchi, M. Suzuki, and A. Yoshimura Post-ischemic inflammation in the brain Front. Immunol. 3 2012 132
44. K. Takeda, and S. Akira Toll-like receptors in innate immunity Int. Immunol. 17 2005 1 14
45. B. Tang, H. Qiao, F. Meng, and X. Sun Glycyrrhizin attenuates endotoxin- induced acute liver injury after partial hepatectomy in rats Braz. J. Med. Biol. Res. 40 2007 1637 1646
46. J. Vogel, C. Mobius, and W. Kuschinsky Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining Stroke 30 1999 1134 1141 (Pubitemid 29211638)
47. B. Wali, T. Ishrat, F. Atif, F. Hua, D.G. Stein, and I. Sayeed Glibenclamide administration attenuates infarct volume, hemispheric swelling, and functional impairments following permanent focal cerebral ischemia in rats Stroke Res. Treat. 2012 2012 460909
48. Q. Wang, X.N. Tang, and M.A. Yenari The inflammatory response in stroke J. Neuroimmunol. 184 2007 53 68 (Pubitemid 46365991)
49. T.M. Woodruff, J. Thundyil, S.C. Tang, C.G. Sobey, S.M. Taylor, and T.V. Arumugam Pathophysiology, treatment, and animal and cellular models of human ischemic stroke Mol. Neurodegener. 6 2011 11
50. C. Zhang, M. Chopp, Y. Cui, L. Wang, R. Zhang, L. Zhang, M. Lu, A. Szalad, E. Doppler, M. Hitzl, and Z.G. Zhang Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke J. Neurosci. Res. 88 2010 3275 3281
51. L. Zhang, T. Schallert, Z.G. Zhang, Q. Jiang, P. Arniego, Q. Li, M. Lu, and M. Chopp A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia J. Neurosci. Methods 117 2002 207 214 (Pubitemid 34721338)
52. W. Zhou, A. Liesz, H. Bauer, C. Sommer, B. Lahrmann, N. Valous, N. Grabe, and R. Veltkamp Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models Brain Pathol. 23 2012 34 44